The Syrian cardiomyopathic hamster (BIO14.6), that develops both muscular dystrophy and progressive cardiomyopathy, is widely used as an animal model of autosomal recessive cardiomyopathy mimicking human hypertrophic cardiomyopathy, and five genes have been proposed as strong candidates for the cause of cardiomyopathy. We recently mapped the cardiomyopathy locus of the hamster to the centromeric region of chromosome 9qa2.1-bl by construction of a genetic linkage map of the Syrian hamster. Thus, we analyzed the loci of the five candidate genes, a tropomyosin, cardiac troponin T, adhalin, calpain 3 and cardiac myosin binding protein-C, by the FISH method, and found that these genes were mapped on the distal portion of chromosome 12qa5 and 4pa2 and the proximal portion of chromosomes 9qb7, lqcl.l and Iqb3, respectively. These results provide strong evidence that the five candidate genes previously proposed are not related to the hamster cardiomyopathy.
The Syrian cardiomyopathic hamster (BIO14.6), is an analysis of the causative gene for the cardiomyopathic inbred strain with a hereditary abnormality in skele-hamster. tal and cardiac muscles involving ventricular and atrial
In this study, we used FISH analysis to evaluate five hypertrophy with subsequent development of congestive candidate genes which were previously strong candidate heart failure. 1 " 4 This strain has been widely used as an genes for cardiomyopathy or a certain type of muscular animal model for human forms of hypertrophic cardiomy-dystrophy. The five candidate genes are a-tropomyosin opathy and congestive heart failure, in which cardiac (a-TM), 7 cardiac troponin T (TNT), 7 cardiac myosin cellular necrosis accompanied by a loss of sarcolemmal binding protein-C (MyBP-C), 8 ' 9 adhalin (ADH) 10 and integrity begins 30-40 days after birth. It was first es-calpain 3 (CANP3). 11 The first three genes have been tablished by Homburger et al. 1 in 1962 that the disease reported to be the causative genes for human-type hyphenotype is inherited by a single locus in an autoso-pertrophic cardiomyopathies. ADH is reported to be mal recessive mode with complete penetrance. Several specifically deficient in the BIO14.6 strain, 12 and misbiochemical abnormalities in the cardiomyopathic ham-sense mutation of this gene causes a certain type of musster have been described, 4 ' 5 but the genetic defect of the cular dystrophy. 10 Mutations in CANP3 also cause an-BIO14.6 strain has not been identified.
other type of muscular dystrophy. For these reasons, we Recently, we constructed a genetic linkage map of the chose these genes for further analyses. Syrian hamster 6 exonl was amplified using for ward-ex 1. a, CTT TCC TTG AAG GTA GCT GTA T, reverse-exl.m, GAG GTG CTG AGT GAG AGG AC and used for screening hamster cDNA libraries. PCR conditions used for the amplification were denaturation at 94°C for 3 min, followed by 30 cycles of 94°C for 1 min, 58°C for 1 min, 72°C for 1 min, with a final extension at 72°C for 3 min. Probes were labeled by random priming to a specific activity of 10 8 cpm//ig. Screening was performed using standard techniques, and clones were purified through tertiary screening. 13 The identity of each clone was confirmed by one-pass sequence on both strands using an ABI 377 sequencer.
Since cDNA clones for a-TM, cardiac TNT and cardiac MyBP-C do not produce a clear signal in the FISH analysis, we used the corresponding phage and cosmid genomic clones. A phage library was constructed using ADASHII vector (Stratagene) with partially Mboldigested hamster genomic DNA. A cosmid library was constructed using pWE15 vector (Stratagene) with Mboldigested hamster genomic DNA. Probes used for screening the library were amplified from ACN hamster genomic DNA using the primer pairs designed from the conserved region between human and rat: a-TM 7 (accession number, M16433, J02689), forward329, CGT AAG CTG GTC ATC ATC GA, reverse721, CTT ATC CTC TGC AGC CAT TA.; cardiac TNT 7 (accession number, M80829), forwardl5101, GCG TAT TCG CAA TGA ACG AG, reversel8093, GAT CCT GTT TCG CAG AAC GT; PCR conditions used for the amplification were as described above. The amplified fragments were used to screen the genomic library. The cosmid clone corresponding to cardiac MyBP-C gene was screened using the Syrian hamster cDNA specific for cardiac MyBP-C. The probe used for screening the Syrian hamster heart cDNA library was amplified by PCR from reverse-transcribed (RT) human heart mRNA. The primers (accession number, X84075) 9 used for the RT-PCR were forwardl785, GTG CCC GAC AGC CGC ATA A; reverse2103, GCC TGG CTG GGG CCT TAT T. These clones were confirmed by one-pass sequence of both ends.
Mapping of Five Candidate Genes for Cardiomyopathic Hamster by Direct R-and GBand FISH Analysis
a-TM, cardiac TNT and cardiac MyBP-C genes, which cause hypertrophic cardiomyopathy in humans, were subjected to FISH analysis.
The direct Rbanding FISH method used in this study has been described previously.
14 ' 15 The karyotyping of the Syrian hamster was determined by following the described nomenclature. 16 As shown in Fig. 1 , a-TM, cardiac TNT and cardiac MyBP-C genes were localized subregionally to the distal portion of the Syrian hamster chromosome 12qa5 ( Fig.  la and lb), 4pa2 (Fig. lc and Id) and the proximal portion of chromosome Iqb3 (Fig. li and lj) , respectively. Thus, these genes could be excluded as candidate genes for the cm locus. Together with our previous results, 6 which excluded the /3-myosin heavy chain gene 17 as a candidate by linkage analysis, our findings have eliminated all causative genes reported for human-type of hypertrophic cardiomyopathies as possible causes of hamster cardiomyopathy.
Roberds et al. 12 reported that ADH (50 kDa dystrophin-associated glycoprotein) is specifically deficient in skeletal and cardiac muscles of the BIO 14.6 strain and suggested it as a strong candidate for hamster cardiomyopathy. They reported that the cDNA sequence of BIO14.6 is normal 18 but conducted no genetic analysis. We mapped the ADH gene onto Syrian hamster chromosome 9qb7 (Fig. le and If) by FISH, which completely excluded the ADH gene itself from responsibility for this cardiomyopathy. Thus, the deficiency of adhalin glycoprotein may be a secondary change of the disease.
All of these candidate genes are structural components of muscle tissue. Recently, a novel pathological mechanism leading to muscular dystrophy has been reported, 11 in which the enzyme, CANP3 (named for calcium-activated neutral protease large polypeptide L3 or calpain 3), was eventually proved to cause limbgirdle muscular dystrophy type 2A. Although the precise pathological etiology is unknown, the mutations of the gene eventually resulted in degeneration of muscle fiber. Therefore, we also tried to determine whether CANP3 is the responsible gene. However, FISH analysis using hamster CANP3 cDNA showed its localization on chromosome lqcl.l (Fig. lg and lh) , thus eliminating it as a candidate.
In conclusion, we determined the chromosomal localization of five candidate genes for hamster cardiomyopathy including a-TM, cardiac TNT, ADH, CANP3 and cardiac MyBP-C. These results strongly suggest that these five genes are not related to cm which is located on chromosome 9qa2.1-bl. Other structural components of skeletal or cardiac muscle, or other mechanisms yet to be reported should be considered to identify the defective gene in the BIO14.6 cardiomyopathic hamster.
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